Loading viewer...
earnings
Format: PDF earnings
Incyte Corporation's third-quarter 2016 financial and corporate update presented November 1, 2016, covering Jakafi sales growth, regulatory milestones for baricitinib, and pipeline advancement across JAK inhibitors and immuno-oncology programs. The presentation outlines the company's 2016 financial guidance and strategic expectations for product development timelines and market opportunities.
earnings
21 Pages
earnings
50 Pages
Coca-Cola Amatil
Atlas Air Worldwide Q2 2016 Earnings Review
earningsearnings
15 Pages
Atlas Air Worldwide Holdings
C.H. Robinson Q2 2023 Earnings Presentation
earningsearnings
25 Pages
C.H. Robinson Worldwide Inc